• Reference Citation Analysis
  • v
  • v
  • Find an Article
Find an Article PDF (4667255)   Today's Articles (149)   Subscriber (51746)
For: Taylor AJ. Another clinical evidence straw on the $4 billion ezetimibe camel's back. Atherosclerosis 2011;218:23-5. [DOI: 10.1016/j.atherosclerosis.2011.05.028] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 05/20/2011] [Accepted: 05/24/2011] [Indexed: 11/15/2022]
Number Cited by Other Article(s)
1
Gryn SE, Hegele RA. Ezetimibe plus simvastatin for the treatment of hypercholesterolemia. Expert Opin Pharmacother 2015;16:1255-62. [DOI: 10.1517/14656566.2015.1041504] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
2
Gouni-Berthold I, Mikhailidis DP, Rizzo M. Clinical benefits of ezetimibe use: is absence of proof, proof of absence? Expert Opin Pharmacother 2012;13:1985-8. [DOI: 10.1517/14656566.2012.720974] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/05/2022]
PrevPage 1 of 1 1Next
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA